glp 1 for dementia GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation Repurposing glucagon-like peptide-1 receptor agonists

GLP-1 RA-Related Facial Aging The rapid and significant weight loss induced by GLP-1 RAs often leads to a noticeable reduction in facial fat pad volume, along with a decline in skin collagen, elastin, and essential nutrients

11 Neuroprotective effects GLP-1 medicines reduce stroke incidence, as shown in major cardiovascular outcome trials including SELECT, SUSTAIN-6, REWIND, and PIONEER 6

Skin aging is the process in which the quality of dermis and epidermis deteriorates, and the skin appears thinner and drier with profound wrinkles and with less elasticity

It is not for use in people with diabetic ketoacidosis

[DOI] [PMC free article] [PubMed] [Google Scholar] 8.Scrocchi L.A., Brown T.J., MaClusky N., Brubaker P.L., Auerbach A.B., Joyner A.L., Drucker D.J